Trial Profile
Effects of perindopril/indapamide/amlodipine fixed-dose combination (FDC) on peripheral and central blood pressure (BP) parameters in patients with uncontrolled hypertension.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2018
Price :
$35
*
At a glance
- Drugs Amlodipine/indapamide/perindopril (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 18 Sep 2018 New trial record
- 29 Aug 2018 Results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology